Abstract
Surgery of mid-to-low rectal cancer is still considered challenging. Transanal total mesorectal excision has been proposed to facilitate the mesorectal dissection, gain sphincter-saving procedures, and reduce functional sequelae. Few studies have investigated long-term functional outcomes and patients’ quality of life. The aim of this study was to compare functional outcomes and quality of life before and after transanal total mesorectal excision in 1-year follow-up. Between February 2016 and April 2019, 51 patients with mid- or low rectal cancer undergoing transanal total mesorectal excision at Fondazione Policlinico Universitario “A. Gemelli” were enrolled. Neoadjuvant radiochemotherapy was administered to locally advanced cancers. Before and after the surgical procedure, patients were examined collecting clinical data, LARS score, CCFIS, SF36 and FIQL, performing anorectal manometry and endoanal ultrasonography. Thirty-three patients were eligible and completed the 12 months follow-up. After treatment, six patients (18.2%) had minor or major LARS. A mild but significant increase of CCFIS was documented. Only the mean resting pressure significantly decreased at follow-up. No sphincter lesions were documented. FIQL assessment showed significant reduction of lifestyle, coping/behaviour, and embarrassment, while an increase of general health was assessed by SF36. At both uni- and multivariate analyses the neoadjuvant radiochemotherapy had a not negligible impact. Transanal total mesorectal excision represents a safe approach to patients treated for mid- or low rectal cancer. The functional sequelae can be limited in severity, with a low incidence of minor/major LARS, particularly faecal incontinence. These results are comparable to those obtained by the conventional total mesorectal excision.





References
Heald RJ (1979) A new approach to rectal cancer. Br J Hosp Med 22(3):277–81
de Lacy FB, Chadi SA, Berho M et al (2018) The future of rectal cancer surgery: a narrative review of an international symposium. Surg Innov 25(5):525–35
Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24(5):1205–10
Emile SH, de Lacy FB, Keller DS et al (2018) Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom. World J Gastrointest Surg 10(3):28–39
Buess G, Theiss R, Gunther M, Hutterer F, Pichlmaier H (1985) Endoscopic surgery in the rectum. Endoscopy 17(1):31–5
Velthuis S, van den Boezem PB, van der Peet DL, Cuesta MA, Sietses C (2019) Feasibility study of transanal total mesorectal excision. Br J Surg 100(6):828-31; discussion 31.
Vignali A, Elmore U, Milone M, Rosati R (2019) Transanal total mesorectal excision (TaTME): current status and future perspectives. Updates Surg. 71(1):29–37
European Society of Coloproctology Collaborating G (2018) An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME). Colorectal Dis 20(Suppl 6):33–46
Caycedo-Marulanda A, Ma G, Jiang HY (2018) Transanal total mesorectal excision (taTME) in a single-surgeon setting: refinements of the technique during the learning phase. Tech Coloproctol 22(6):433–43
Atallah S, Albert M, Larach S (2010) Transanal minimally invasive surgery: a giant leap forward. Surg Endosc 24(9):2200–5
Kneist W, Wachter N, Paschold M, Kauff DW, Rink AD, Lang H (2016) Midterm functional results of taTME with neuromapping for low rectal cancer. Tech Coloproctol 20(1):41–9
Bjoern MX, Nielsen S, Perdawood SK (2019) Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J Gastrointest Surg 23(8):1623–30
Veltcamp Helbach M, Koedam TWA, Knol JJ et al (2019) Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc 33(1):79–87
Bjoern MX, Perdawood SK (2020) Manometric assessment of anorectal function after transanal total mesorectal excision. Tech Coloproctol 24(3):231–6
Keller DS, Reali C, Spinelli A et al (2019) Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision. Br J Surg 106(4):364–6
Kneist W, Hanke L, Kauff DW, Lang H (2016) Surgeons’ assessment of internal anal sphincter nerve supply during TaTME - inbetween expectations and reality. Minim Invasive Ther Allied Technol 25(5):241–6
Koedam TW, van Ramshorst GH, Deijen CL et al (2017) Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol 21(1):25–33
Rouanet P, Mourregot A, Azar CC et al (2013) Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum 56(4):408–15
Tuech JJ, Karoui M, Lelong B et al (2015) A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 261(2):228–33
Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13(Suppl 1):S31–S4
Persiani R, Biondi A, Pennestri F et al (2018) Transanal total mesorectal excision vs laparoscopic total mesorectal excision in the treatment of low and middle rectal cancer: a propensity score matching analysis. Dis Colon Rectum 61(7):809–16
Emmertsen KJ, Laurberg S (2012) Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 255(5):922–8
Solh WWSDSSIDGW, Ghoniem GM, Wexner SD (2008) Scoring systems. Dysfunction PF. Springer, London
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–83
Rockwood TH, Church JM, Fleshman JW et al (2000) Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 43(1):9–16
Brouwer NPM, Bos A, Lemmens V et al (2018) An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. Int J Cancer 143(11):2758–66
Kalloo AN, Singh VK, Jagannath SB et al (2004) Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity. Gastrointest Endosc 60(1):114–7
Atallah S, Martin-Perez B, Albert M et al (2014) Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol 18(5):473–80
Bjorn MX, Perdawood SK (2015) Transanal total mesorectal excision—a systematic review. Dan Med J 62(7):1–1
van der Heijden JAG, Koeter T, Smits LJH et al (2020) Functional complaints and quality of life after transanal total mesorectal excision: a meta-analysis. Br J Sur 107(5):489–98
Rubinkiewicz M, Zarzycki P, Czerwinska A et al (2018) A quest for sphincter-saving surgery in ultralow rectal tumours-a single-centre cohort study. World J Surg Oncol 16(1):218
Elmore U, Vignali A, Cossu A, De Nardi P, Lemma M, Parise P (2017) Transanal total mesorectal excision for rectal cancer. Preliminary experience. Surg Endosc 107(5):489
De Angelis N, Portigliotti L, Azoulay D, Brunetti F (2015) Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of the literature. Langenbecks Arch Surg 400(8):945–59
Hanke L, Kauff D, Lang H, Kneist W (2017) Ano(neo-)rectal Function After Transanal Total Mesorectal Excision (TaTME) for Primary Rectal Cancer. 134th Congress of the German Society of Surgery (DGCH); Munich, Germany: European Surgical Research.
Mosquera C, Licardie E, Bravo D, Madarro C, Rosales J, Romero JA (2019) Fecal incontinence after surgical treatment of middle–low rectal cancer. Laparoscopic low anterior resection versus tatme. Surg Endosc
Camilleri-Brennan J, Ruta DA, Steele RJ (2002) Patient generated index: new instrument for measuring quality of life in patients with rectal cancer. World J Surg 26(11):1354–9
Vironen JH, Kairaluoma M, Aalto AM, Kellokumpu IH (2006) Impact of functional results on quality of life after rectal cancer surgery. Dis Colon Rectum 49(5):568–78
Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL (2012) Anterior resection syndrome. Lancet Oncol 13(9):e403-8
Ribas Y, Aguilar F, Jovell-Fernandez E, Cayetano L, Navarro-Luna A, Munoz-Duyos A (2017) Clinical application of the LARS score: results from a pilot study. Int J Colorectal Dis 32(3):409–18
Ribas Y, Munoz-Duyos A (2019) How useful is the LARS score in the evaluation and treatment of LARS? Tech Coloproctol 23(2):195–6
Funding
The authors received no specific funding for this work.
Author information
Authors and Affiliations
Contributions
VDS: substantial contributions to the conception or design of the work; acquisition, analysis and interpretation of data for the work. Drafting the work or revising it critically for important intellectual content. Final approval of the version to be published. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. RP, AB and CR contributed equally to this work: substantial contributions to the conception and design of the work; acquisition, analysis and interpretation of data for the work. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy and integrity of any part of the work are appropriately investigated and resolved. FL, AP, PC, RO, AM and DD contributed equally to this work: substantial contributions to the acquisition of data for the work. Final approval of the version to be published. AC: substantial contributions to the conception or design of the work; drafting the work and revising it critically for important intellectual content; final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
The authors declare under their responsibility that all the procedures followed in this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Availability of data and material
The datasets generated during the current study are available from the corresponding author on reasonable request.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Simone, V., Persiani, R., Biondi, A. et al. One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision. Updates Surg 73, 157–164 (2021). https://doi.org/10.1007/s13304-020-00919-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-020-00919-y